S. 4378 · 117th Congress · Senate

Hatch-Waxman Improvement Act of 2022

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Jun 13, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Hatch-Waxman Improvement Act of 2022

This bill extends through FY2026 provisions that establish a period of market exclusivity for certain new drugs with single enantiomers (i.e., one of a pair of molecules that are mirror images of one another).

Action Timeline

2
  1. JUN 13, 2022•IntroReferral

    Introduced in Senate

  2. JUN 13, 2022•IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Jun 13, 2022

Active